GE HealthCare Technologies updates FY2024 earnings forecast to $4.20-$4.35 EPS, following improved Q4 2023 results with 5% revenue growth to $5.

GE HealthCare Technologies (NASDAQ:GEHC) has updated its FY 2024 earnings guidance to 4.200-4.350 EPS, and its FY 2024 guidance to $4.20-$4.35 EPS. The company reported a 5% year-over-year increase in Q4 2023 revenue, and a 7% increase for the full year. In Q4 2023, net income margin declined to 7.7% from 11.2% the previous year, while full-year margin decreased to 8% from 10.4%.

February 06, 2024
31 Articles

Further Reading